in a phase ii study of acr for solid tumours , response was achieved in carcinoma of oesophagus ( 1/3 ) , stomach ( 12/84 , 14 % ) , gall bladder ( 1/4 ) , pancreas ( 1/8 ) , lung ( 4/30 , 13 % ) , breast ( 6/33 , 18 % ) , uterus ( 1/4 ) , ovary ( 3/9 , 33 % ) , head and neck ( 1/5 ) and sarcoma ( 1/5 ) .
C0280100
solid tumours
C0152018
carcinoma of oesophagus